Bionovate Technologies Corp
OTC:BIIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its Industry Average (19.2), the stock would be worth $0 (100% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0 | $0 |
0%
|
| Industry Average | 19.2 | $0 |
-100%
|
| Country Average | 13.1 | $0 |
-100%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CH |
B
|
Bionovate Technologies Corp
OTC:BIIO
|
775.4 USD | 0 | -0 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170B USD | 56.3 | 59.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
160.6B USD | 16.6 | 25.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126.1B USD | 24.8 | 38.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.5B USD | 14.7 | 23.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
97.4B USD | 20.6 | 32.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40B EUR | 13.2 | 18.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 30.7 | 45.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.7B USD | 37.9 | 42.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.1B USD | 12.8 | 24.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32B USD | 16.7 | 21.5 |
Market Distribution
Other Multiples
Bionovate Technologies Corp
Glance View
Bionovate Technologies Corp. engages in the acquisition and development of technologies based on protected and wholly-owned internet protocol in the medical devices sector. The company is headquartered in Cham, Zug and currently employs 0 full-time employees. The company went IPO on 2014-03-28. The firm is involved in the review of opportunities for merger and acquisition. The firm has no operations.
